Results 131 to 140 of about 1,936,479 (187)

SMPR: a structure-enhanced multimodal drug‒disease prediction model for drug repositioning and cold start. [PDF]

J Cheminform
Dong X, Miao R, Zhang S, Jia S, Zhang L, Liang Y, Zhang J, Zhu YZ.   +7 more
europepmc   +1 more source

Genome-wide association study -Driven drug repositioning for the treatment of insomnia. [PDF]

J Genet Eng Biotechnol
Satria RD, Adikusuma W, Sukorini U, Avitasari DE, Kusuma Harahap IS, Setia Lesmana MH, Irham LM, Fatimah Harahap NI, Rinastiti P, Wardhana DA, Prabasaktya RW, Lin CF, Paramitasari A, Kusumadewi AF.   +13 more
europepmc   +1 more source

MVSGDR: multi-view stacked graph convolutional network for drug repositioning. [PDF]

Brief Bioinform
Gu G, Wu H, Han H, Lin Z, Sun Y, Xie G, Su Q, Liu Z.   +7 more
europepmc   +1 more source

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19. [PDF]

Clin Transl Sci
Ben Ghezala I, Peiffer-Smadja N, Solas C, Nougairède A, Touret F, Bardou M.   +5 more
europepmc   +1 more source

Drug Repositioning of Pegbing® for Essential Thrombocythemia: Insights from PK/PD Modeling and Extrapolation. [PDF]

Clin Pharmacol Ther
Jian W, Yin Y, Chen R, Xue J, Gu J, Du Z, He R, Zhou T.   +7 more
europepmc   +1 more source

Improving computational drug repositioning through multi-source disease similarity networks. [PDF]

Sci Rep
Le DH.
europepmc   +1 more source

Drug repositioning model based on knowledge graph embedding. [PDF]

Sci Rep
He S, Zhao X.
europepmc   +1 more source

Enhancing drug repositioning: A multi-class ensemble model for drug-target interaction prediction with action type categorization. [PDF]

PLoS One
Jafari Khouzani L, Sardari S, Jafari Khouzani S, Pérez-Sánchez H, Ghasemi F.   +4 more
europepmc   +1 more source

Drug repositioning of regorafenib for renal cell carcinoma identifies <i>DDR2</i>‑associated sensitivity in ACHN models. [PDF]

Korean J Physiol Pharmacol
Moon J, Vo VTA, Nhat LT, Eom M, Jeong Y.
europepmc   +1 more source

Drug Repositioning and Repurposing for Disease-Modifying Effects in Parkinson's Disease. [PDF]

J Mov Disord
Jeong SH, Lee PH.
europepmc   +1 more source